^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in sodium chloride 0.45%.

^d Injected via Y-site into an administration set running azithromycin.

^e Final concentration after mixing.

^f Tested in both dextrose 5% and sodium chloride 0.9%.

^g Tested in dextrose 5% with human albumin 2 mg/mL.

^h With human albumin 0.1%.

ⁱ Lyophilized formulation tested.

^j Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^k Tested in sterile water for injection.

^l Tested in Ringer’s injection, lactated.

^m Quinupristin and dalfopristin components combined.

ⁿ Test performed using the Cubicin formulation.

^o Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^p Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^q Sodium carbonate-containing formulation tested.

^r Test performed using the formulation WITH edetate disodium.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.